

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | L-phenylalanine catabolic process (GO:0006559) | 6.20593029 |
| 2 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 6.20593029 |
| 3 | L-phenylalanine metabolic process (GO:0006558) | 5.95688331 |
| 4 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 5.95688331 |
| 5 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 5.50766159 |
| 6 | establishment of integrated proviral latency (GO:0075713) | 5.47401846 |
| 7 | aromatic amino acid family catabolic process (GO:0009074) | 5.47154748 |
| 8 | alpha-linolenic acid metabolic process (GO:0036109) | 5.16400904 |
| 9 | glyoxylate metabolic process (GO:0046487) | 5.07273964 |
| 10 | kynurenine metabolic process (GO:0070189) | 4.90341567 |
| 11 | bile acid biosynthetic process (GO:0006699) | 4.90123378 |
| 12 | tryptophan catabolic process (GO:0006569) | 4.83188168 |
| 13 | indole-containing compound catabolic process (GO:0042436) | 4.83188168 |
| 14 | indolalkylamine catabolic process (GO:0046218) | 4.83188168 |
| 15 | L-serine metabolic process (GO:0006563) | 4.82285108 |
| 16 | regulation of gene silencing by RNA (GO:0060966) | 4.78780820 |
| 17 | regulation of posttranscriptional gene silencing (GO:0060147) | 4.78780820 |
| 18 | regulation of gene silencing by miRNA (GO:0060964) | 4.78780820 |
| 19 | sulfur amino acid catabolic process (GO:0000098) | 4.73217970 |
| 20 | IMP biosynthetic process (GO:0006188) | 4.72024065 |
| 21 | tyrosine metabolic process (GO:0006570) | 4.71687017 |
| 22 | lysine catabolic process (GO:0006554) | 4.66201134 |
| 23 | lysine metabolic process (GO:0006553) | 4.66201134 |
| 24 | cysteine metabolic process (GO:0006534) | 4.65967456 |
| 25 | IMP metabolic process (GO:0046040) | 4.59530635 |
| 26 | high-density lipoprotein particle remodeling (GO:0034375) | 4.59474264 |
| 27 | tryptophan metabolic process (GO:0006568) | 4.58861900 |
| 28 | protein carboxylation (GO:0018214) | 4.57393217 |
| 29 | peptidyl-glutamic acid carboxylation (GO:0017187) | 4.57393217 |
| 30 | urea cycle (GO:0000050) | 4.55445034 |
| 31 | urea metabolic process (GO:0019627) | 4.55445034 |
| 32 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 4.52563438 |
| 33 | regulation of protein activation cascade (GO:2000257) | 4.51284737 |
| 34 | negative regulation of fibrinolysis (GO:0051918) | 4.50764476 |
| 35 | complement activation, alternative pathway (GO:0006957) | 4.46206815 |
| 36 | homocysteine metabolic process (GO:0050667) | 4.36759754 |
| 37 | regulation of triglyceride catabolic process (GO:0010896) | 4.33706858 |
| 38 | chromatin remodeling at centromere (GO:0031055) | 4.32775534 |
| 39 | regulation of fibrinolysis (GO:0051917) | 4.32655609 |
| 40 | cellular ketone body metabolic process (GO:0046950) | 4.28666602 |
| 41 | regulation of complement activation (GO:0030449) | 4.27629149 |
| 42 | amino-acid betaine metabolic process (GO:0006577) | 4.20630354 |
| 43 | ketone body metabolic process (GO:1902224) | 4.20137861 |
| 44 | aromatic amino acid family metabolic process (GO:0009072) | 4.19663739 |
| 45 | reverse cholesterol transport (GO:0043691) | 4.19282844 |
| 46 | CENP-A containing nucleosome assembly (GO:0034080) | 4.18173242 |
| 47 | nitrogen cycle metabolic process (GO:0071941) | 4.17815582 |
| 48 | pre-miRNA processing (GO:0031054) | 4.16622225 |
| 49 | bile acid metabolic process (GO:0008206) | 4.15967636 |
| 50 | ribosome assembly (GO:0042255) | 4.15501052 |
| 51 | serine family amino acid catabolic process (GO:0009071) | 4.15423312 |
| 52 | mitotic metaphase plate congression (GO:0007080) | 4.12062110 |
| 53 | negative regulation of mitotic metaphase/anaphase transition (GO:0045841) | 4.11365722 |
| 54 | negative regulation of metaphase/anaphase transition of cell cycle (GO:1902100) | 4.11365722 |
| 55 | negative regulation of mitotic sister chromatid segregation (GO:0033048) | 4.11365722 |
| 56 | negative regulation of mitotic sister chromatid separation (GO:2000816) | 4.11365722 |
| 57 | negative regulation of sister chromatid segregation (GO:0033046) | 4.11365722 |
| 58 | regulation of helicase activity (GO:0051095) | 4.09959693 |
| 59 | short-chain fatty acid metabolic process (GO:0046459) | 4.08056813 |
| 60 | protein-lipid complex remodeling (GO:0034368) | 4.07805236 |
| 61 | macromolecular complex remodeling (GO:0034367) | 4.07805236 |
| 62 | plasma lipoprotein particle remodeling (GO:0034369) | 4.07805236 |
| 63 | protein localization to kinetochore (GO:0034501) | 4.07393439 |
| 64 | protein complex localization (GO:0031503) | 4.02791577 |
| 65 | anterior/posterior axis specification, embryo (GO:0008595) | 4.01877930 |
| 66 | alpha-amino acid catabolic process (GO:1901606) | 3.99540318 |
| 67 | regulation of cholesterol esterification (GO:0010872) | 3.99496087 |
| 68 | negative regulation of chromosome segregation (GO:0051985) | 3.97585413 |
| 69 | plasma lipoprotein particle clearance (GO:0034381) | 3.97488647 |
| 70 | positive regulation of SMAD protein import into nucleus (GO:0060391) | 3.97477722 |
| 71 | establishment of viral latency (GO:0019043) | 3.95994417 |
| 72 | acylglycerol homeostasis (GO:0055090) | 3.89803175 |
| 73 | triglyceride homeostasis (GO:0070328) | 3.89803175 |
| 74 | acetyl-CoA metabolic process (GO:0006084) | 3.81965046 |
| 75 | histone exchange (GO:0043486) | 3.79509665 |
| 76 | purine nucleobase biosynthetic process (GO:0009113) | 3.79315336 |
| 77 | 2-oxoglutarate metabolic process (GO:0006103) | 3.77937810 |
| 78 | cellular amino acid catabolic process (GO:0009063) | 3.77659802 |
| 79 | cellular modified amino acid catabolic process (GO:0042219) | 3.77400982 |
| 80 | phospholipid efflux (GO:0033700) | 3.77380926 |
| 81 | paraxial mesoderm development (GO:0048339) | 3.76548691 |
| 82 | * cellular glucuronidation (GO:0052695) | 3.75146403 |
| 83 | dicarboxylic acid biosynthetic process (GO:0043650) | 3.74090629 |
| 84 | glutamate metabolic process (GO:0006536) | 3.74056442 |
| 85 | ethanol oxidation (GO:0006069) | 3.73696004 |
| 86 | fatty acid beta-oxidation (GO:0006635) | 3.71234676 |
| 87 | coenzyme catabolic process (GO:0009109) | 3.70826667 |
| 88 | negative regulation of sterol transport (GO:0032372) | 3.69545494 |
| 89 | negative regulation of cholesterol transport (GO:0032375) | 3.69545494 |
| 90 | regulation of mitotic cell cycle spindle assembly checkpoint (GO:0090266) | 3.68063854 |
| 91 | regulation of mitotic spindle checkpoint (GO:1903504) | 3.68063854 |
| 92 | mitotic spindle checkpoint (GO:0071174) | 3.67597835 |
| 93 | aspartate family amino acid catabolic process (GO:0009068) | 3.66393793 |
| 94 | bile acid and bile salt transport (GO:0015721) | 3.62285307 |
| 95 | fatty acid oxidation (GO:0019395) | 3.61977024 |
| 96 | spindle checkpoint (GO:0031577) | 3.61961329 |
| 97 | positive regulation of fatty acid beta-oxidation (GO:0032000) | 3.61658787 |
| 98 | regulation of metaphase/anaphase transition of cell cycle (GO:1902099) | 3.59815124 |
| 99 | regulation of mitotic metaphase/anaphase transition (GO:0030071) | 3.59815124 |
| 100 | nuclear pore complex assembly (GO:0051292) | 3.59524486 |
| 101 | lipid oxidation (GO:0034440) | 3.58819156 |
| 102 | phospholipid homeostasis (GO:0055091) | 3.54740101 |
| 103 | negative regulation of DNA-dependent DNA replication (GO:2000104) | 3.53738956 |
| 104 | positive regulation of lipid catabolic process (GO:0050996) | 3.53138637 |
| 105 | fatty acid transmembrane transport (GO:1902001) | 3.51422007 |
| 106 | low-density lipoprotein particle remodeling (GO:0034374) | 3.51183847 |
| 107 | DNA replication checkpoint (GO:0000076) | 3.50396129 |
| 108 | cholesterol efflux (GO:0033344) | 3.49664675 |
| 109 | regulation of sister chromatid segregation (GO:0033045) | 3.49528549 |
| 110 | regulation of mitotic sister chromatid separation (GO:0010965) | 3.49528549 |
| 111 | regulation of mitotic sister chromatid segregation (GO:0033047) | 3.49528549 |
| 112 | DNA replication-independent nucleosome organization (GO:0034724) | 3.48301456 |
| 113 | DNA replication-independent nucleosome assembly (GO:0006336) | 3.48301456 |
| 114 | fibrinolysis (GO:0042730) | 3.46988357 |
| 115 | fatty acid catabolic process (GO:0009062) | 3.46648388 |
| 116 | mitotic spindle assembly checkpoint (GO:0007094) | 3.46603593 |
| 117 | monocarboxylic acid catabolic process (GO:0072329) | 3.46537208 |
| 118 | organic acid catabolic process (GO:0016054) | 3.45421863 |
| 119 | carboxylic acid catabolic process (GO:0046395) | 3.45421863 |
| 120 | benzene-containing compound metabolic process (GO:0042537) | 3.44214698 |
| 121 | serine family amino acid biosynthetic process (GO:0009070) | 3.42881928 |
| 122 | plasma lipoprotein particle assembly (GO:0034377) | 3.41759699 |
| 123 | metaphase plate congression (GO:0051310) | 3.41078805 |
| 124 | indolalkylamine metabolic process (GO:0006586) | 3.38121225 |
| 125 | valine metabolic process (GO:0006573) | 3.37494069 |
| 126 | carnitine metabolic process (GO:0009437) | 3.37442268 |
| 127 | spindle assembly checkpoint (GO:0071173) | 3.36590361 |
| 128 | amine catabolic process (GO:0009310) | 3.36172237 |
| 129 | cellular biogenic amine catabolic process (GO:0042402) | 3.36172237 |
| 130 | serine family amino acid metabolic process (GO:0009069) | 3.34353376 |
| 131 | drug catabolic process (GO:0042737) | 3.33325359 |
| 132 | nuclear pore organization (GO:0006999) | 3.32676970 |
| 133 | positive regulation of fatty acid oxidation (GO:0046321) | 3.32312578 |
| 134 | transcytosis (GO:0045056) | 3.31588406 |
| 135 | arginine metabolic process (GO:0006525) | 3.31413662 |
| 136 | * glucuronate metabolic process (GO:0019585) | 3.30810274 |
| 137 | * uronic acid metabolic process (GO:0006063) | 3.30810274 |
| 138 | telomere maintenance via telomerase (GO:0007004) | 3.29416994 |
| 139 | negative regulation of mitosis (GO:0045839) | 3.28577017 |
| 140 | glycine metabolic process (GO:0006544) | 3.28496777 |
| 141 | regulation of cholesterol homeostasis (GO:2000188) | 3.28126182 |
| 142 | very-low-density lipoprotein particle assembly (GO:0034379) | 3.27257503 |
| 143 | aldehyde catabolic process (GO:0046185) | 3.26778582 |
| 144 | negative regulation of lipase activity (GO:0060192) | 3.26177272 |
| 145 | cellular protein complex localization (GO:0034629) | 3.25605753 |
| 146 | tricarboxylic acid cycle (GO:0006099) | 3.25445178 |
| 147 | opsonization (GO:0008228) | 3.24565575 |
| 148 | regulation of chromosome segregation (GO:0051983) | 3.24545748 |
| 149 | mitotic G2/M transition checkpoint (GO:0044818) | 3.24336965 |
| 150 | cholesterol homeostasis (GO:0042632) | 3.23725395 |
| 151 | regulation of cholesterol metabolic process (GO:0090181) | 3.23625961 |
| 152 | nucleobase biosynthetic process (GO:0046112) | 3.22574018 |
| 153 | carnitine shuttle (GO:0006853) | 3.21393782 |
| 154 | protein-lipid complex assembly (GO:0065005) | 3.20987273 |
| 155 | negative regulation of telomerase activity (GO:0051974) | 3.17821253 |
| 156 | regulation of cell fate specification (GO:0042659) | 3.17556215 |
| 157 | negative regulation of DNA recombination (GO:0045910) | 3.17253558 |
| 158 | NADH metabolic process (GO:0006734) | 3.11868361 |
| 159 | somatic diversification of immune receptors via somatic mutation (GO:0002566) | 3.11490913 |
| 160 | somatic hypermutation of immunoglobulin genes (GO:0016446) | 3.11490913 |
| 161 | L-alpha-amino acid transmembrane transport (GO:1902475) | 3.11256723 |
| 162 | DNA double-strand break processing (GO:0000729) | 3.09322814 |
| 163 | regulation of histone H3-K9 methylation (GO:0051570) | 3.08822084 |
| 164 | female gonad development (GO:0008585) | 3.07959732 |
| 165 | DNA strand elongation involved in DNA replication (GO:0006271) | 3.05125609 |
| 166 | proteasome assembly (GO:0043248) | 3.04846386 |
| 167 | heterochromatin organization (GO:0070828) | 3.04620576 |
| 168 | gap junction assembly (GO:0016264) | 3.02669710 |
| 169 | DNA replication-dependent nucleosome organization (GO:0034723) | 3.00220931 |
| 170 | DNA replication-dependent nucleosome assembly (GO:0006335) | 3.00220931 |
| 171 | RNA-dependent DNA replication (GO:0006278) | 2.99659118 |
| 172 | response to X-ray (GO:0010165) | 2.94284901 |
| 173 | negative regulation of nuclear division (GO:0051784) | 2.93246059 |
| 174 | ventricular cardiac muscle cell development (GO:0055015) | 2.89632806 |
| 175 | protein localization to chromosome, centromeric region (GO:0071459) | 2.88567883 |
| 176 | negative regulation of proteasomal ubiquitin-dependent protein catabolic process (GO:0032435) | 2.86839069 |
| 177 | cell fate commitment involved in formation of primary germ layer (GO:0060795) | 2.84650158 |
| 178 | DNA strand elongation (GO:0022616) | 2.83419092 |
| 179 | negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051436) | 2.81935194 |
| 180 | regulation of SMAD protein import into nucleus (GO:0060390) | 2.79502775 |
| 181 | mitotic G2 DNA damage checkpoint (GO:0007095) | 2.78720380 |
| 182 | regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051439) | 2.76565118 |
| 183 | regulation of telomere maintenance via telomerase (GO:0032210) | 2.74319931 |
| 184 | double-strand break repair via nonhomologous end joining (GO:0006303) | 2.73444214 |
| 185 | non-recombinational repair (GO:0000726) | 2.73444214 |
| 186 | bundle of His cell to Purkinje myocyte communication (GO:0086069) | 2.71820841 |
| 187 | regulation of cofactor metabolic process (GO:0051193) | 2.69523096 |
| 188 | regulation of coenzyme metabolic process (GO:0051196) | 2.69523096 |
| 189 | regulation of acetyl-CoA biosynthetic process from pyruvate (GO:0010510) | 2.69186942 |
| 190 | lung-associated mesenchyme development (GO:0060484) | 2.67395741 |
| 191 | negative regulation of fibroblast apoptotic process (GO:2000270) | 2.66368680 |
| 192 | positive regulation of chromosome segregation (GO:0051984) | 2.66132233 |
| 193 | establishment of chromosome localization (GO:0051303) | 2.65526513 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 9.78028362 |
| 2 | E2F7_22180533_ChIP-Seq_HELA_Human | 7.07574048 |
| 3 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 6.85080336 |
| 4 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 5.89976923 |
| 5 | * LXR_22158963_ChIP-Seq_LIVER_Mouse | 5.50083424 |
| 6 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 5.44409106 |
| 7 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 5.18000035 |
| 8 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 4.30912587 |
| 9 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 3.57614919 |
| 10 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 3.53302714 |
| 11 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 3.45294627 |
| 12 | SALL1_21062744_ChIP-ChIP_HESCs_Human | 3.00037726 |
| 13 | KLF2_18264089_ChIP-ChIP_MESCs_Mouse | 2.97806103 |
| 14 | KLF5_18264089_ChIP-ChIP_MESCs_Mouse | 2.97806103 |
| 15 | KLF4_18264089_ChIP-ChIP_MESCs_Mouse | 2.97806103 |
| 16 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 2.92409834 |
| 17 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 2.91431130 |
| 18 | AR_21909140_ChIP-Seq_LNCAP_Human | 2.88609167 |
| 19 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 2.77097049 |
| 20 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 2.73703602 |
| 21 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 2.62424673 |
| 22 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 2.61439144 |
| 23 | NACC1_18358816_ChIP-ChIP_MESCs_Mouse | 2.56648922 |
| 24 | NANOG_18700969_ChIP-ChIP_MESCs_Mouse | 2.56493039 |
| 25 | KDM5B_21448134_ChIP-Seq_MESCs_Mouse | 2.43366488 |
| 26 | POU5F1_18700969_ChIP-ChIP_MESCs_Mouse | 2.43102732 |
| 27 | CHD1_19587682_ChIP-ChIP_MESCs_Mouse | 2.33573024 |
| 28 | NANOG_16153702_ChIP-ChIP_HESCs_Human | 2.32687325 |
| 29 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 2.32262314 |
| 30 | CLOCK_20551151_ChIP-Seq_293T_Human | 2.31799114 |
| 31 | MYC_19079543_ChIP-ChIP_MESCs_Mouse | 2.30761189 |
| 32 | POU5F1_16153702_ChIP-ChIP_HESCs_Human | 2.27552920 |
| 33 | TCF3_18692474_ChIP-Seq_MEFs_Mouse | 2.26656037 |
| 34 | MYC_19030024_ChIP-ChIP_MESCs_Mouse | 2.15936236 |
| 35 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.95743891 |
| 36 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 1.89647014 |
| 37 | SOX2_16153702_ChIP-ChIP_HESCs_Human | 1.84278055 |
| 38 | MYCN_21190229_ChIP-Seq_SHEP-21N_Human | 1.82947910 |
| 39 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 1.82437013 |
| 40 | * NELFA_20434984_ChIP-Seq_ESCs_Mouse | 1.81656057 |
| 41 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 1.80340871 |
| 42 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.79984517 |
| 43 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 1.76285146 |
| 44 | ELK1_19687146_ChIP-ChIP_HELA_Human | 1.72522292 |
| 45 | SALL4_18804426_ChIP-ChIP_MESCs_Mouse | 1.71768422 |
| 46 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 1.71110487 |
| 47 | TCF3_18692474_ChIP-Seq_MESCs_Mouse | 1.69034270 |
| 48 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 1.68434944 |
| 49 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 1.67873034 |
| 50 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.62415940 |
| 51 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.59906644 |
| 52 | E2F1_18555785_ChIP-Seq_MESCs_Mouse | 1.59195864 |
| 53 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.56945198 |
| 54 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.56631520 |
| 55 | * MYCN_18555785_ChIP-Seq_MESCs_Mouse | 1.54264262 |
| 56 | SOX2_18555785_ChIP-Seq_MESCs_Mouse | 1.51302298 |
| 57 | NANOG_18555785_ChIP-Seq_MESCs_Mouse | 1.49050636 |
| 58 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.45581460 |
| 59 | GATA1_22025678_ChIP-Seq_K562_Human | 1.45041842 |
| 60 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 1.44205819 |
| 61 | MYC_18358816_ChIP-ChIP_MESCs_Mouse | 1.42608084 |
| 62 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 1.40000986 |
| 63 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 1.40000986 |
| 64 | MYBL2_22936984_ChIP-ChIP_MESCs_Mouse | 1.39122142 |
| 65 | * E2F1_21310950_ChIP-Seq_MCF-7_Human | 1.39039332 |
| 66 | NANOG_18358816_ChIP-ChIP_MESCs_Mouse | 1.38364882 |
| 67 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.37599732 |
| 68 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.37422310 |
| 69 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.36668164 |
| 70 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.35468257 |
| 71 | FUS_26573619_Chip-Seq_HEK293_Human | 1.32802402 |
| 72 | HTT_18923047_ChIP-ChIP_STHdh_Human | 1.31615376 |
| 73 | ZIC3_20872845_ChIP-ChIP_MESCs_Mouse | 1.30047545 |
| 74 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.29870460 |
| 75 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.29398932 |
| 76 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 1.29019480 |
| 77 | ASH2L_23239880_ChIP-Seq_MESCs_Mouse | 1.27557595 |
| 78 | PRDM5_23873026_ChIP-Seq_MEFs_Mouse | 1.25936750 |
| 79 | ZFP281_18358816_ChIP-ChIP_MESCs_Mouse | 1.25805986 |
| 80 | POU5F1_18358816_ChIP-ChIP_MESCs_Mouse | 1.24974563 |
| 81 | RBPJ_22232070_ChIP-Seq_NCS_Mouse | 1.22771728 |
| 82 | SOX2_19030024_ChIP-ChIP_MESCs_Mouse | 1.22271260 |
| 83 | NANOG_18692474_ChIP-Seq_MEFs_Mouse | 1.22242983 |
| 84 | WT1_19549856_ChIP-ChIP_CCG9911_Human | 1.21411828 |
| 85 | YY1_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.20832783 |
| 86 | PADI4_21655091_ChIP-ChIP_MCF-7_Human | 1.20340587 |
| 87 | P300_19829295_ChIP-Seq_ESCs_Human | 1.19929171 |
| 88 | * HNF4A_19822575_ChIP-Seq_HepG2_Human | 1.17632356 |
| 89 | ZFX_18555785_ChIP-Seq_MESCs_Mouse | 1.17213683 |
| 90 | EWS_26573619_Chip-Seq_HEK293_Human | 1.16045138 |
| 91 | SOX17_20123909_ChIP-Seq_XEN_Mouse | 1.14185375 |
| 92 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 1.14180113 |
| 93 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.14073402 |
| 94 | HOXD13_18407260_ChIP-ChIP_DEVELOPING-LIMBS_Mouse | 1.11122555 |
| 95 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 1.10145560 |
| 96 | FOXO3_22982991_ChIP-Seq_MACROPHAGES_Mouse | 1.09596191 |
| 97 | SOX2_18692474_ChIP-Seq_MEFs_Mouse | 1.08621864 |
| 98 | POU5F1_18555785_ChIP-Seq_MESCs_Mouse | 1.08312510 |
| 99 | TBX3_20139965_ChIP-Seq_ESCs_Mouse | 1.07907392 |
| 100 | NANOG_16518401_ChIP-PET_MESCs_Mouse | 1.07046008 |
| 101 | TBX3_20139965_ChIP-Seq_MESCs_Mouse | 1.06506660 |
| 102 | * ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 1.05645418 |
| 103 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 1.05596107 |
| 104 | * Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.05398048 |
| 105 | SOX2_18358816_ChIP-ChIP_MESCs_Mouse | 1.04864139 |
| 106 | TRIM28_17542650_ChIP-ChIP_NTERA2_Human | 1.04515520 |
| 107 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 1.04080317 |
| 108 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 1.02905275 |
| 109 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.02451557 |
| 110 | GATA1_26923725_Chip-Seq_HPCs_Mouse | 1.01973002 |
| 111 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 1.01934336 |
| 112 | POU5F1_18347094_ChIP-ChIP_MESCs_Mouse | 1.01265956 |
| 113 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 0.97792314 |
| 114 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 0.97551525 |
| 115 | THAP11_20581084_ChIP-Seq_MESCs_Mouse | 0.97411244 |
| 116 | PPARG_23326641_ChIP-Seq_C3H10T1-2_Mouse | 0.97259213 |
| 117 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 0.97195576 |
| 118 | * TBX20_22080862_ChIP-Seq_HEART_Mouse | 0.96973787 |
| 119 | * TBX20_22328084_ChIP-Seq_HEART_Mouse | 0.96973787 |
| 120 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 0.96494124 |
| 121 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 0.96059480 |
| 122 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 0.95332917 |
| 123 | GATA4_25053715_ChIP-Seq_YYC3_Human | 0.94030331 |
| 124 | NANOG_18347094_ChIP-ChIP_MESCs_Mouse | 0.93987839 |
| 125 | NANOG_18692474_ChIP-Seq_MESCs_Mouse | 0.93345413 |
| 126 | FOXP3_21729870_ChIP-Seq_TREG_Human | 0.92815808 |
| 127 | ZNF263_19887448_ChIP-Seq_K562_Human | 0.92540449 |
| 128 | NANOG_21062744_ChIP-ChIP_HESCs_Human | 0.92439876 |
| 129 | AUTS2_25519132_ChIP-Seq_293T-REX_Human | 0.91530773 |
| 130 | * TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.90614762 |
| 131 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 0.90603758 |
| 132 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 0.90061594 |
| 133 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 0.88905525 |
| 134 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 0.88267430 |
| 135 | TCF3_18467660_ChIP-ChIP_MESCs_Mouse | 0.87431138 |
| 136 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 0.87109569 |
| 137 | CJUN_26792858_Chip-Seq_BT549_Human | 0.86985959 |
| 138 | SOX2_20726797_ChIP-Seq_SW620_Human | 0.85244304 |
| 139 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 0.84593575 |
| 140 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 0.84463291 |
| 141 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 0.78669423 |
| 142 | EGR1_19032775_ChIP-ChIP_M12_Human | 0.77634070 |
| 143 | * RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 0.76645343 |
| 144 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 0.76186544 |
| 145 | RXRA_24833708_ChIP-Seq_LIVER_Mouse | 0.74627759 |
| 146 | SREBP1_19666523_ChIP-Seq_LIVER_Mouse | 0.74585551 |
| 147 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 0.73297723 |
| 148 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 0.72624466 |
| 149 | AR_21572438_ChIP-Seq_LNCaP_Human | 0.70928318 |
| 150 | * BCAT_22108803_ChIP-Seq_LS180_Human | 0.70606091 |
| 151 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 0.67132586 |
| 152 | FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.66974397 |
| 153 | PPARG_20887899_ChIP-Seq_3T3-L1_Mouse | 0.64865497 |
| 154 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 0.64802149 |
| 155 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 0.64632395 |
| 156 | GATA3_24758297_ChIP-Seq_MCF-7_Human | 0.64053418 |
| 157 | CBP_21632823_ChIP-Seq_H3396_Human | 0.63812898 |
| 158 | * CEBPD_21427703_ChIP-Seq_3T3-L1_Mouse | 0.62881616 |
| 159 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 0.61174712 |
| 160 | TP63_23658742_ChIP-Seq_EP156T_Human | 0.60940102 |
| 161 | * FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.60395067 |
| 162 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 0.59319702 |
| 163 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 0.59218875 |
| 164 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 0.58860861 |
| 165 | FOXA1_25552417_ChIP-Seq_VCAP_Human | 0.58441749 |
| 166 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 0.57443618 |
| 167 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 0.56589550 |
| 168 | CDX2_22108803_ChIP-Seq_LS180_Human | 0.56176870 |
| 169 | CEBPB_22108803_ChIP-Seq_LS180_Human | 0.56104904 |
| 170 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 0.56057845 |
| 171 | GATA2_19941826_ChIP-Seq_K562_Human | 0.55386819 |
| 172 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 0.55253135 |
| 173 | * PPARG_20176806_ChIP-Seq_3T3-L1_Mouse | 0.54108337 |
| 174 | RAD21_21589869_ChIP-Seq_MESCs_Mouse | 0.53933694 |
| 175 | RXR_22108803_ChIP-Seq_LS180_Human | 0.53785614 |
| 176 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.52277078 |
| 177 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 0.51578977 |
| 178 | JUN_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.51069220 |
| 179 | * AR_20517297_ChIP-Seq_VCAP_Human | 0.50565753 |
| 180 | * FOXM1_26456572_ChIP-Seq_MCF-7_Human | 0.50262975 |
| 181 | ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.49955079 |
| 182 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 0.49417927 |
| 183 | CSB_26484114_Chip-Seq_FIBROBLAST_Human | 0.49386832 |
| 184 | TP53_18474530_ChIP-ChIP_U2OS_Human | 0.48745900 |
| 185 | RACK7_27058665_Chip-Seq_MCF-7_Human | 0.48199255 |
| 186 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.48180290 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002139_abnormal_hepatobiliary_system | 7.08076121 |
| 2 | MP0003941_abnormal_skin_development | 6.54370831 |
| 3 | MP0005360_urolithiasis | 6.44238800 |
| 4 | MP0005085_abnormal_gallbladder_physiolo | 5.36347972 |
| 5 | MP0005365_abnormal_bile_salt | 5.08321982 |
| 6 | MP0008875_abnormal_xenobiotic_pharmacok | 4.29768563 |
| 7 | MP0003806_abnormal_nucleotide_metabolis | 4.00684652 |
| 8 | MP0004957_abnormal_blastocyst_morpholog | 3.40960403 |
| 9 | MP0003252_abnormal_bile_duct | 3.30416744 |
| 10 | MP0003693_abnormal_embryo_hatching | 3.20951492 |
| 11 | MP0010329_abnormal_lipoprotein_level | 3.15664618 |
| 12 | MP0009840_abnormal_foam_cell | 2.91860570 |
| 13 | MP0009672_abnormal_birth_weight | 2.83383761 |
| 14 | MP0010094_abnormal_chromosome_stability | 2.68774100 |
| 15 | MP0005332_abnormal_amino_acid | 2.67093281 |
| 16 | MP0003111_abnormal_nucleus_morphology | 2.67068608 |
| 17 | MP0003718_maternal_effect | 2.65833800 |
| 18 | MP0010352_gastrointestinal_tract_polyps | 2.64147033 |
| 19 | MP0005083_abnormal_biliary_tract | 2.53523761 |
| 20 | MP0003195_calcinosis | 2.51092973 |
| 21 | MP0008057_abnormal_DNA_replication | 2.40912994 |
| 22 | MP0003890_abnormal_embryonic-extraembry | 2.36664232 |
| 23 | MP0008877_abnormal_DNA_methylation | 2.29161211 |
| 24 | MP0003567_abnormal_fetal_cardiomyocyte | 2.27363085 |
| 25 | MP0008058_abnormal_DNA_repair | 2.26592271 |
| 26 | MP0008932_abnormal_embryonic_tissue | 2.24905779 |
| 27 | MP0001666_abnormal_nutrient_absorption | 2.20251029 |
| 28 | MP0003191_abnormal_cellular_cholesterol | 2.02253957 |
| 29 | MP0002118_abnormal_lipid_homeostasis | 1.97930341 |
| 30 | MP0008007_abnormal_cellular_replicative | 1.94727003 |
| 31 | MP0001730_embryonic_growth_arrest | 1.93830860 |
| 32 | MP0003077_abnormal_cell_cycle | 1.93395670 |
| 33 | MP0003705_abnormal_hypodermis_morpholog | 1.90802647 |
| 34 | MP0004130_abnormal_muscle_cell | 1.86864684 |
| 35 | MP0000609_abnormal_liver_physiology | 1.84939211 |
| 36 | MP0004019_abnormal_vitamin_homeostasis | 1.73957508 |
| 37 | MP0002837_dystrophic_cardiac_calcinosis | 1.72771827 |
| 38 | MP0005319_abnormal_enzyme/_coenzyme | 1.70167343 |
| 39 | MP0003646_muscle_fatigue | 1.69137329 |
| 40 | MP0001188_hyperpigmentation | 1.67440544 |
| 41 | MP0004272_abnormal_basement_membrane | 1.62861506 |
| 42 | MP0001293_anophthalmia | 1.59963617 |
| 43 | MP0000579_abnormal_nail_morphology | 1.59136075 |
| 44 | MP0002138_abnormal_hepatobiliary_system | 1.59135595 |
| 45 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.57825040 |
| 46 | MP0003868_abnormal_feces_composition | 1.46116800 |
| 47 | MP0002796_impaired_skin_barrier | 1.41182967 |
| 48 | MP0003566_abnormal_cell_adhesion | 1.39253461 |
| 49 | MP0009703_decreased_birth_body | 1.38536591 |
| 50 | MP0005408_hypopigmentation | 1.37659105 |
| 51 | MP0008438_abnormal_cutaneous_collagen | 1.36902145 |
| 52 | MP0009697_abnormal_copulation | 1.35322586 |
| 53 | MP0002254_reproductive_system_inflammat | 1.32360033 |
| 54 | MP0001177_atelectasis | 1.32335263 |
| 55 | MP0000350_abnormal_cell_proliferation | 1.31086830 |
| 56 | MP0003186_abnormal_redox_activity | 1.30741165 |
| 57 | MP0003136_yellow_coat_color | 1.29813159 |
| 58 | MP0001299_abnormal_eye_distance/ | 1.26099896 |
| 59 | MP0000749_muscle_degeneration | 1.26069533 |
| 60 | MP0000372_irregular_coat_pigmentation | 1.25110712 |
| 61 | MP0005451_abnormal_body_composition | 1.24234308 |
| 62 | MP0000751_myopathy | 1.23875656 |
| 63 | MP0003656_abnormal_erythrocyte_physiolo | 1.22822507 |
| 64 | MP0001672_abnormal_embryogenesis/_devel | 1.22304145 |
| 65 | MP0005380_embryogenesis_phenotype | 1.22304145 |
| 66 | MP0009643_abnormal_urine_homeostasis | 1.18537059 |
| 67 | MP0003011_delayed_dark_adaptation | 1.18062320 |
| 68 | MP0001764_abnormal_homeostasis | 1.17996996 |
| 69 | MP0002085_abnormal_embryonic_tissue | 1.17665580 |
| 70 | MP0004036_abnormal_muscle_relaxation | 1.17422833 |
| 71 | MP0003123_paternal_imprinting | 1.15525829 |
| 72 | MP0002697_abnormal_eye_size | 1.14897489 |
| 73 | MP0010030_abnormal_orbit_morphology | 1.14824409 |
| 74 | MP0002084_abnormal_developmental_patter | 1.14445350 |
| 75 | MP0000604_amyloidosis | 1.14430776 |
| 76 | MP0006036_abnormal_mitochondrial_physio | 1.13411646 |
| 77 | MP0003937_abnormal_limbs/digits/tail_de | 1.13165849 |
| 78 | MP0001697_abnormal_embryo_size | 1.12602472 |
| 79 | MP0009384_cardiac_valve_regurgitation | 1.12458808 |
| 80 | MP0001881_abnormal_mammary_gland | 1.11619895 |
| 81 | MP0002971_abnormal_brown_adipose | 1.11573427 |
| 82 | MP0010630_abnormal_cardiac_muscle | 1.10701081 |
| 83 | MP0005670_abnormal_white_adipose | 1.10535426 |
| 84 | MP0003690_abnormal_glial_cell | 1.05855060 |
| 85 | MP0010368_abnormal_lymphatic_system | 1.05358038 |
| 86 | MP0005666_abnormal_adipose_tissue | 1.05102632 |
| 87 | MP0003984_embryonic_growth_retardation | 1.03514955 |
| 88 | MP0002088_abnormal_embryonic_growth/wei | 1.03382680 |
| 89 | MP0002080_prenatal_lethality | 1.02320010 |
| 90 | MP0005395_other_phenotype | 1.02213703 |
| 91 | MP0000762_abnormal_tongue_morphology | 1.01811453 |
| 92 | MP0003119_abnormal_digestive_system | 1.00810689 |
| 93 | MP0000747_muscle_weakness | 0.99631306 |
| 94 | MP0006292_abnormal_olfactory_placode | 0.99416137 |
| 95 | MP0005330_cardiomyopathy | 0.97247547 |
| 96 | MP0004233_abnormal_muscle_weight | 0.95968486 |
| 97 | MP0002269_muscular_atrophy | 0.94256106 |
| 98 | MP0009764_decreased_sensitivity_to | 0.94074786 |
| 99 | MP0000598_abnormal_liver_morphology | 0.91993994 |
| 100 | MP0004087_abnormal_muscle_fiber | 0.91274885 |
| 101 | MP0003950_abnormal_plasma_membrane | 0.91094737 |
| 102 | MP0001849_ear_inflammation | 0.90886778 |
| 103 | MP0004197_abnormal_fetal_growth/weight/ | 0.90506037 |
| 104 | MP0002086_abnormal_extraembryonic_tissu | 0.88552618 |
| 105 | MP0005275_abnormal_skin_tensile | 0.86947376 |
| 106 | MP0005620_abnormal_muscle_contractility | 0.86661839 |
| 107 | MP0002233_abnormal_nose_morphology | 0.85352594 |
| 108 | MP0003329_amyloid_beta_deposits | 0.83160269 |
| 109 | MP0005058_abnormal_lysosome_morphology | 0.80650956 |
| 110 | MP0004185_abnormal_adipocyte_glucose | 0.80197057 |
| 111 | MP0005636_abnormal_mineral_homeostasis | 0.79915266 |
| 112 | MP0003137_abnormal_impulse_conducting | 0.79619905 |
| 113 | MP0005647_abnormal_sex_gland | 0.79105372 |
| 114 | MP0010307_abnormal_tumor_latency | 0.78087924 |
| 115 | MP0005334_abnormal_fat_pad | 0.77382898 |
| 116 | MP0004145_abnormal_muscle_electrophysio | 0.76676771 |
| 117 | MP0002078_abnormal_glucose_homeostasis | 0.76036170 |
| 118 | MP0009763_increased_sensitivity_to | 0.74779279 |
| 119 | MP0005376_homeostasis/metabolism_phenot | 0.74276179 |
| 120 | MP0004084_abnormal_cardiac_muscle | 0.74241649 |
| 121 | MP0001485_abnormal_pinna_reflex | 0.74093205 |
| 122 | MP0009642_abnormal_blood_homeostasis | 0.70913250 |
| 123 | MP0001915_intracranial_hemorrhage | 0.70857605 |
| 124 | MP0003221_abnormal_cardiomyocyte_apopto | 0.69322307 |
| 125 | MP0003121_genomic_imprinting | 0.67971207 |
| 126 | MP0001286_abnormal_eye_development | 0.67654377 |
| 127 | MP0008469_abnormal_protein_level | 0.65622250 |
| 128 | MP0002111_abnormal_tail_morphology | 0.65568153 |
| 129 | MP0005535_abnormal_body_temperature | 0.65329259 |
| 130 | MP0001661_extended_life_span | 0.65159203 |
| 131 | MP0005266_abnormal_metabolism | 0.64494161 |
| 132 | MP0002972_abnormal_cardiac_muscle | 0.64153442 |
| 133 | MP0003279_aneurysm | 0.63626206 |
| 134 | MP0005248_abnormal_Harderian_gland | 0.62069410 |
| 135 | MP0002106_abnormal_muscle_physiology | 0.61987763 |
| 136 | MP0005166_decreased_susceptibility_to | 0.60315131 |
| 137 | MP0001756_abnormal_urination | 0.60160673 |
| 138 | MP0000759_abnormal_skeletal_muscle | 0.59425686 |
| 139 | MP0003075_altered_response_to | 0.59360156 |
| 140 | MP0001544_abnormal_cardiovascular_syste | 0.58739475 |
| 141 | MP0005385_cardiovascular_system_phenoty | 0.58739475 |
| 142 | MP0005503_abnormal_tendon_morphology | 0.57653158 |
| 143 | MP0005084_abnormal_gallbladder_morpholo | 0.56631344 |
| 144 | MP0000230_abnormal_systemic_arterial | 0.56270728 |
| 145 | MP0005171_absent_coat_pigmentation | 0.55616245 |
| 146 | MP0002332_abnormal_exercise_endurance | 0.55133982 |
| 147 | MP0006035_abnormal_mitochondrial_morpho | 0.55059805 |
| 148 | MP0006138_congestive_heart_failure | 0.53260620 |
| 149 | MP0002295_abnormal_pulmonary_circulatio | 0.53163113 |
| 150 | MP0005369_muscle_phenotype | 0.52881472 |
| 151 | MP0004215_abnormal_myocardial_fiber | 0.52567737 |
| 152 | MP0005375_adipose_tissue_phenotype | 0.52141987 |
| 153 | MP0002108_abnormal_muscle_morphology | 0.51580550 |
| 154 | MP0002090_abnormal_vision | 0.48516120 |
| 155 | MP0008775_abnormal_heart_ventricle | 0.48411844 |
| 156 | MP0000343_altered_response_to | 0.48205373 |
| 157 | MP0005164_abnormal_response_to | 0.48178564 |
| 158 | MP0004043_abnormal_pH_regulation | 0.48169764 |
| 159 | MP0000750_abnormal_muscle_regeneration | 0.47863878 |
| 160 | MP0004381_abnormal_hair_follicle | 0.46704152 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Deep venous thrombosis (HP:0002625) | 5.98985712 |
| 2 | Intrahepatic cholestasis (HP:0001406) | 5.85299865 |
| 3 | Xanthomatosis (HP:0000991) | 5.54102685 |
| 4 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 5.51153401 |
| 5 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 4.99536440 |
| 6 | Hypobetalipoproteinemia (HP:0003563) | 4.83967848 |
| 7 | Prolonged partial thromboplastin time (HP:0003645) | 4.83826699 |
| 8 | Hyperlipoproteinemia (HP:0010980) | 4.66086589 |
| 9 | Hypoalphalipoproteinemia (HP:0003233) | 4.36712159 |
| 10 | Hypolipoproteinemia (HP:0010981) | 4.33183302 |
| 11 | Hyperammonemia (HP:0001987) | 4.23514878 |
| 12 | Abnormality of the labia minora (HP:0012880) | 4.23468551 |
| 13 | Complement deficiency (HP:0004431) | 4.15474546 |
| 14 | Ketosis (HP:0001946) | 4.04279473 |
| 15 | Hypoglycemic coma (HP:0001325) | 3.99256976 |
| 16 | Colon cancer (HP:0003003) | 3.96562032 |
| 17 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 3.95632217 |
| 18 | Hyperglycinemia (HP:0002154) | 3.85756522 |
| 19 | Hyperglycinuria (HP:0003108) | 3.77671574 |
| 20 | Abnormality of serine family amino acid metabolism (HP:0010894) | 3.73112082 |
| 21 | Abnormality of glycine metabolism (HP:0010895) | 3.73112082 |
| 22 | Epidermoid cyst (HP:0200040) | 3.70388436 |
| 23 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 3.69051395 |
| 24 | Multiple enchondromatosis (HP:0005701) | 3.48744479 |
| 25 | Abnormality of the common coagulation pathway (HP:0010990) | 3.46565308 |
| 26 | Joint hemorrhage (HP:0005261) | 3.41615053 |
| 27 | Abnormality of fatty-acid metabolism (HP:0004359) | 3.41457135 |
| 28 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 3.38616814 |
| 29 | Ketoacidosis (HP:0001993) | 3.35269305 |
| 30 | Abnormality of methionine metabolism (HP:0010901) | 3.31285804 |
| 31 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 3.29846474 |
| 32 | Nephroblastoma (Wilms tumor) (HP:0002667) | 3.29535106 |
| 33 | Fat malabsorption (HP:0002630) | 3.26119415 |
| 34 | Myoglobinuria (HP:0002913) | 3.20713597 |
| 35 | Embryonal renal neoplasm (HP:0011794) | 3.15202752 |
| 36 | Exercise-induced muscle cramps (HP:0003710) | 3.11837254 |
| 37 | Exercise-induced myalgia (HP:0003738) | 3.11391443 |
| 38 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 3.07526119 |
| 39 | Abnormality of the intrinsic pathway (HP:0010989) | 3.03364818 |
| 40 | Abnormality of complement system (HP:0005339) | 2.98837139 |
| 41 | Septo-optic dysplasia (HP:0100842) | 2.93296386 |
| 42 | Biliary tract neoplasm (HP:0100574) | 2.89931005 |
| 43 | Ependymoma (HP:0002888) | 2.88620062 |
| 44 | Hypercholesterolemia (HP:0003124) | 2.87972727 |
| 45 | Rhabdomyosarcoma (HP:0002859) | 2.86762077 |
| 46 | Choanal stenosis (HP:0000452) | 2.83582357 |
| 47 | Abnormal lung lobation (HP:0002101) | 2.83061753 |
| 48 | Pancreatic islet-cell hyperplasia (HP:0004510) | 2.76975695 |
| 49 | Dicarboxylic aciduria (HP:0003215) | 2.72266286 |
| 50 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 2.72266286 |
| 51 | Skin nodule (HP:0200036) | 2.70659589 |
| 52 | Muscle fiber inclusion bodies (HP:0100299) | 2.69236196 |
| 53 | Agnosia (HP:0010524) | 2.67863139 |
| 54 | Abnormality of serum amino acid levels (HP:0003112) | 2.67108954 |
| 55 | Hepatocellular carcinoma (HP:0001402) | 2.66013929 |
| 56 | Myocardial infarction (HP:0001658) | 2.63426735 |
| 57 | Stenosis of the external auditory canal (HP:0000402) | 2.63397625 |
| 58 | Birth length less than 3rd percentile (HP:0003561) | 2.62337305 |
| 59 | Abnormality of purine metabolism (HP:0004352) | 2.60673657 |
| 60 | Hyperbilirubinemia (HP:0002904) | 2.59763887 |
| 61 | Conjugated hyperbilirubinemia (HP:0002908) | 2.57343802 |
| 62 | Metabolic acidosis (HP:0001942) | 2.56809701 |
| 63 | Muscle fiber cytoplasmatic inclusion bodies (HP:0100303) | 2.55039832 |
| 64 | Rhabdomyolysis (HP:0003201) | 2.54268798 |
| 65 | Neoplasm of the colon (HP:0100273) | 2.51255497 |
| 66 | Abnormality of nucleobase metabolism (HP:0010932) | 2.49143695 |
| 67 | Rimmed vacuoles (HP:0003805) | 2.47963135 |
| 68 | Gout (HP:0001997) | 2.45049663 |
| 69 | Cerebral edema (HP:0002181) | 2.44208657 |
| 70 | Steatorrhea (HP:0002570) | 2.44051247 |
| 71 | Abnormal gallbladder morphology (HP:0012437) | 2.43787374 |
| 72 | Cholelithiasis (HP:0001081) | 2.42497152 |
| 73 | Neoplasm of the small intestine (HP:0100833) | 2.41655323 |
| 74 | Increased serum pyruvate (HP:0003542) | 2.40104594 |
| 75 | Lethargy (HP:0001254) | 2.39837945 |
| 76 | Palpitations (HP:0001962) | 2.38663838 |
| 77 | Delayed CNS myelination (HP:0002188) | 2.38100739 |
| 78 | Vascular calcification (HP:0004934) | 2.35852138 |
| 79 | Nemaline bodies (HP:0003798) | 2.35341629 |
| 80 | Maternal diabetes (HP:0009800) | 2.34935070 |
| 81 | Type 1 muscle fiber predominance (HP:0003803) | 2.34101433 |
| 82 | Symptomatic seizures (HP:0011145) | 2.33653800 |
| 83 | Reduced antithrombin III activity (HP:0001976) | 2.32559122 |
| 84 | Generalized aminoaciduria (HP:0002909) | 2.31400206 |
| 85 | Neoplasm of the adrenal gland (HP:0100631) | 2.29425258 |
| 86 | Abnormal gallbladder physiology (HP:0012438) | 2.27856034 |
| 87 | Cholecystitis (HP:0001082) | 2.27856034 |
| 88 | Chromosomal breakage induced by crosslinking agents (HP:0003221) | 2.27734474 |
| 89 | Abnormality of pyrimidine metabolism (HP:0004353) | 2.26083771 |
| 90 | Systemic lupus erythematosus (HP:0002725) | 2.24723055 |
| 91 | Cortical dysplasia (HP:0002539) | 2.24602523 |
| 92 | Hydroxyprolinuria (HP:0003080) | 2.24338596 |
| 93 | Abnormality of proline metabolism (HP:0010907) | 2.24338596 |
| 94 | Cardiovascular calcification (HP:0011915) | 2.23435471 |
| 95 | Spontaneous abortion (HP:0005268) | 2.20602507 |
| 96 | Abnormality of glycolysis (HP:0004366) | 2.20443916 |
| 97 | Chromsome breakage (HP:0040012) | 2.18946838 |
| 98 | Neoplasm of the rectum (HP:0100743) | 2.18315580 |
| 99 | Megaloblastic anemia (HP:0001889) | 2.17668815 |
| 100 | Hypoglycemic seizures (HP:0002173) | 2.16827078 |
| 101 | Ovarian neoplasm (HP:0100615) | 2.14749951 |
| 102 | Abnormal cartilage morphology (HP:0002763) | 2.14320198 |
| 103 | Medulloblastoma (HP:0002885) | 2.13261198 |
| 104 | Hyporeflexia of lower limbs (HP:0002600) | 2.12250187 |
| 105 | Abnormal hair whorl (HP:0010721) | 2.11658312 |
| 106 | Uterine neoplasm (HP:0010784) | 2.08789562 |
| 107 | Muscle fiber splitting (HP:0003555) | 2.07341029 |
| 108 | Mitral stenosis (HP:0001718) | 2.06227376 |
| 109 | Asymmetric septal hypertrophy (HP:0001670) | 2.05788069 |
| 110 | Sensorimotor neuropathy (HP:0007141) | 2.05692689 |
| 111 | Selective tooth agenesis (HP:0001592) | 2.04948755 |
| 112 | Hepatoblastoma (HP:0002884) | 2.02551051 |
| 113 | Vomiting (HP:0002013) | 2.01703509 |
| 114 | Chronic bronchitis (HP:0004469) | 2.01551217 |
| 115 | Abnormality of the salivary glands (HP:0010286) | 2.01300306 |
| 116 | Malignant gastrointestinal tract tumors (HP:0006749) | 2.00743896 |
| 117 | Gastrointestinal carcinoma (HP:0002672) | 2.00743896 |
| 118 | Increased purine levels (HP:0004368) | 2.00070018 |
| 119 | Hyperuricemia (HP:0002149) | 2.00070018 |
| 120 | Absent septum pellucidum (HP:0001331) | 1.99357284 |
| 121 | Esophageal varix (HP:0002040) | 1.98757711 |
| 122 | Progressive external ophthalmoplegia (HP:0000590) | 1.98648153 |
| 123 | Malnutrition (HP:0004395) | 1.98524145 |
| 124 | Spastic diplegia (HP:0001264) | 1.98472901 |
| 125 | Gonadotropin excess (HP:0000837) | 1.98414004 |
| 126 | Meckel diverticulum (HP:0002245) | 1.98345404 |
| 127 | Abnormal tarsal ossification (HP:0008369) | 1.97826706 |
| 128 | Muscle stiffness (HP:0003552) | 1.97690575 |
| 129 | Right ventricular cardiomyopathy (HP:0011663) | 1.97553461 |
| 130 | Hyperinsulinemic hypoglycemia (HP:0000825) | 1.97098874 |
| 131 | Abnormality of the septum pellucidum (HP:0007375) | 1.96313109 |
| 132 | Back pain (HP:0003418) | 1.95270027 |
| 133 | Late onset (HP:0003584) | 1.94464164 |
| 134 | Hyperglycemia (HP:0003074) | 1.93823886 |
| 135 | Abnormality of chromosome stability (HP:0003220) | 1.93439019 |
| 136 | Clitoromegaly (HP:0000057) | 1.92458789 |
| 137 | Protuberant abdomen (HP:0001538) | 1.92184327 |
| 138 | Neonatal onset (HP:0003623) | 1.90989336 |
| 139 | Abnormality of the clitoris (HP:0000056) | 1.90880591 |
| 140 | Proximal tubulopathy (HP:0000114) | 1.88276754 |
| 141 | Amyloidosis (HP:0011034) | 1.87864332 |
| 142 | Abnormality of the Achilles tendon (HP:0005109) | 1.87160774 |
| 143 | Muscle hypertrophy of the lower extremities (HP:0008968) | 1.86971227 |
| 144 | Pterygium (HP:0001059) | 1.86885319 |
| 145 | Ventricular tachycardia (HP:0004756) | 1.86097848 |
| 146 | Enlarged kidneys (HP:0000105) | 1.85779609 |
| 147 | Methylmalonic acidemia (HP:0002912) | 1.84277818 |
| 148 | Abnormality of the gallbladder (HP:0005264) | 1.83309943 |
| 149 | Pancreatitis (HP:0001733) | 1.83275204 |
| 150 | Decreased muscle mass (HP:0003199) | 1.82708556 |
| 151 | Distal arthrogryposis (HP:0005684) | 1.82438541 |
| 152 | Abnormality of homocysteine metabolism (HP:0010919) | 1.81877893 |
| 153 | Homocystinuria (HP:0002156) | 1.81877893 |
| 154 | Irritability (HP:0000737) | 1.81320922 |
| 155 | Calf muscle hypertrophy (HP:0008981) | 1.80918145 |
| 156 | Myelomeningocele (HP:0002475) | 1.80487257 |
| 157 | Neck muscle weakness (HP:0000467) | 1.80206231 |
| 158 | Abnormality of the ileum (HP:0001549) | 1.76112675 |
| 159 | Short hallux (HP:0010109) | 1.75963529 |
| 160 | Bifid tongue (HP:0010297) | 1.71741346 |
| 161 | Duodenal stenosis (HP:0100867) | 1.71534007 |
| 162 | Small intestinal stenosis (HP:0012848) | 1.71534007 |
| 163 | Aplasia/Hypoplasia of the sternum (HP:0006714) | 1.69352253 |
| 164 | Shoulder girdle muscle weakness (HP:0003547) | 1.68981292 |
| 165 | Calcaneovalgus deformity (HP:0001848) | 1.68901033 |
| 166 | Breast carcinoma (HP:0003002) | 1.68559713 |
| 167 | EMG: myopathic abnormalities (HP:0003458) | 1.68448760 |
| 168 | Sudden death (HP:0001699) | 1.67660934 |
| 169 | Fused cervical vertebrae (HP:0002949) | 1.67557266 |
| 170 | Areflexia of lower limbs (HP:0002522) | 1.67417281 |
| 171 | Supernumerary spleens (HP:0009799) | 1.66935064 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | BCKDK | 4.98043000 |
| 2 | BUB1 | 4.09388903 |
| 3 | TTK | 3.88635113 |
| 4 | MST1R | 3.78244354 |
| 5 | OBSCN | 3.53475936 |
| 6 | TSSK6 | 3.49639422 |
| 7 | CDC7 | 3.40088986 |
| 8 | TRIB3 | 3.27884126 |
| 9 | SIK1 | 3.13420304 |
| 10 | TNIK | 3.04394330 |
| 11 | MKNK2 | 3.02367618 |
| 12 | TTN | 2.89304992 |
| 13 | PLK3 | 2.86310809 |
| 14 | PKN2 | 2.84675662 |
| 15 | MKNK1 | 2.80818098 |
| 16 | MST4 | 2.72350778 |
| 17 | ERN1 | 2.47597391 |
| 18 | EIF2AK3 | 2.40550025 |
| 19 | FGFR4 | 2.31993665 |
| 20 | PHKG2 | 2.30972411 |
| 21 | PHKG1 | 2.30972411 |
| 22 | PIK3CG | 2.27230718 |
| 23 | ZAK | 2.09188072 |
| 24 | TAF1 | 2.06603721 |
| 25 | INSRR | 2.04867139 |
| 26 | MET | 1.93130768 |
| 27 | VRK2 | 1.89712776 |
| 28 | SRPK1 | 1.85159022 |
| 29 | BRSK2 | 1.82933988 |
| 30 | PDK4 | 1.78303318 |
| 31 | PDK3 | 1.78303318 |
| 32 | TRIM28 | 1.75655111 |
| 33 | LATS1 | 1.72686794 |
| 34 | PLK4 | 1.69428382 |
| 35 | ERBB4 | 1.65871683 |
| 36 | NEK9 | 1.64928284 |
| 37 | PINK1 | 1.64519212 |
| 38 | FRK | 1.64098307 |
| 39 | NLK | 1.51553600 |
| 40 | PLK1 | 1.51522373 |
| 41 | ACVR1B | 1.51482318 |
| 42 | MAP2K3 | 1.47780809 |
| 43 | MAP2K4 | 1.45722226 |
| 44 | PIK3CA | 1.44829059 |
| 45 | MAP3K3 | 1.44677347 |
| 46 | ALK | 1.44445134 |
| 47 | STK38L | 1.42942658 |
| 48 | MAP3K7 | 1.41085340 |
| 49 | WNK3 | 1.40606451 |
| 50 | LMTK2 | 1.40417813 |
| 51 | NUAK1 | 1.39560115 |
| 52 | PTK6 | 1.34187483 |
| 53 | EPHB1 | 1.33203158 |
| 54 | PDK2 | 1.31541324 |
| 55 | FLT3 | 1.23147097 |
| 56 | VRK1 | 1.22696050 |
| 57 | MAPK12 | 1.19019116 |
| 58 | STK16 | 1.16273641 |
| 59 | BMPR1B | 1.14833658 |
| 60 | FGFR2 | 1.14727639 |
| 61 | TAOK3 | 1.14727483 |
| 62 | PRKAA2 | 1.12870504 |
| 63 | MAPK11 | 1.11530026 |
| 64 | EIF2AK1 | 1.05824919 |
| 65 | EPHA3 | 1.03902747 |
| 66 | MAP3K10 | 1.00836097 |
| 67 | CDK19 | 0.99447027 |
| 68 | BMX | 0.97703076 |
| 69 | EIF2AK2 | 0.97192366 |
| 70 | RIPK1 | 0.96458860 |
| 71 | DDR2 | 0.95615676 |
| 72 | NEK1 | 0.94385212 |
| 73 | STK24 | 0.92675945 |
| 74 | WEE1 | 0.91046713 |
| 75 | MAP3K9 | 0.89684249 |
| 76 | TGFBR2 | 0.87791758 |
| 77 | PAK4 | 0.84338523 |
| 78 | ABL2 | 0.83908625 |
| 79 | DYRK2 | 0.82566850 |
| 80 | MYLK | 0.82343050 |
| 81 | TRPM7 | 0.78529518 |
| 82 | OXSR1 | 0.78022933 |
| 83 | DYRK3 | 0.77258266 |
| 84 | TYK2 | 0.72425466 |
| 85 | CAMK2G | 0.70677626 |
| 86 | PRKAA1 | 0.70534939 |
| 87 | PDGFRA | 0.69883043 |
| 88 | NME1 | 0.68949196 |
| 89 | JAK1 | 0.68929587 |
| 90 | TIE1 | 0.68839676 |
| 91 | JAK2 | 0.68606649 |
| 92 | PAK3 | 0.68170316 |
| 93 | DMPK | 0.68003476 |
| 94 | PLK2 | 0.66149397 |
| 95 | ATM | 0.64685745 |
| 96 | PDPK1 | 0.63642787 |
| 97 | AURKB | 0.63443562 |
| 98 | FGFR3 | 0.63060278 |
| 99 | GSK3A | 0.62279335 |
| 100 | MAP2K1 | 0.61066694 |
| 101 | STK4 | 0.60220347 |
| 102 | SGK3 | 0.59926107 |
| 103 | CHEK2 | 0.59286637 |
| 104 | BRSK1 | 0.59160238 |
| 105 | TGFBR1 | 0.59086925 |
| 106 | TBK1 | 0.58095987 |
| 107 | CAMK1D | 0.55848206 |
| 108 | LRRK2 | 0.53363959 |
| 109 | PRKACG | 0.53172813 |
| 110 | BRAF | 0.52783208 |
| 111 | RET | 0.52663583 |
| 112 | DAPK1 | 0.52090895 |
| 113 | CSNK1G1 | 0.52050002 |
| 114 | CHEK1 | 0.51425814 |
| 115 | ATR | 0.51345811 |
| 116 | PBK | 0.51226011 |
| 117 | CSNK1E | 0.50881504 |
| 118 | MAP3K11 | 0.50117200 |
| 119 | MAPK4 | 0.49929815 |
| 120 | MAP2K6 | 0.49849907 |
| 121 | FER | 0.49380156 |
| 122 | PASK | 0.49084649 |
| 123 | MARK3 | 0.48934060 |
| 124 | PRKDC | 0.47430332 |
| 125 | KDR | 0.47418040 |
| 126 | STK39 | 0.47135947 |
| 127 | NEK2 | 0.46481790 |
| 128 | PTK2 | 0.46239605 |
| 129 | ROCK1 | 0.45602027 |
| 130 | BCR | 0.44421763 |
| 131 | STK3 | 0.44227921 |
| 132 | MAP3K12 | 0.43141732 |
| 133 | DAPK2 | 0.42825607 |
| 134 | MAPK7 | 0.42721293 |
| 135 | PRKD1 | 0.42475142 |
| 136 | PRKCQ | 0.42226652 |
| 137 | WNK4 | 0.41912702 |
| 138 | PRKG2 | 0.41761418 |
| 139 | KSR2 | 0.41697932 |
| 140 | PDK1 | 0.41096309 |
| 141 | PRKCZ | 0.41046568 |
| 142 | CSNK2A1 | 0.39108559 |
| 143 | CASK | 0.38555934 |
| 144 | MAP3K5 | 0.38407970 |
| 145 | LATS2 | 0.38192845 |
| 146 | SGK2 | 0.37851194 |
| 147 | SGK223 | 0.37412750 |
| 148 | SGK494 | 0.37412750 |
| 149 | IGF1R | 0.37019651 |
| 150 | EPHB2 | 0.36759646 |
| 151 | ERBB2 | 0.35911788 |
| 152 | YES1 | 0.35753180 |
| 153 | CDK1 | 0.35640156 |
| 154 | EGFR | 0.35288887 |
| 155 | CSNK2A2 | 0.34783482 |
| 156 | MAP3K8 | 0.34124731 |
| 157 | FGFR1 | 0.33918501 |
| 158 | CDK7 | 0.31703457 |
| 159 | TAOK2 | 0.31273467 |
| 160 | CDK6 | 0.31139993 |
| 161 | RPS6KA4 | 0.30852938 |
| 162 | CAMK2D | 0.30042506 |
| 163 | CDK2 | 0.29855345 |
| 164 | MAP3K1 | 0.29732919 |
| 165 | ERBB3 | 0.28476991 |
| 166 | PAK1 | 0.28296646 |
| 167 | PAK2 | 0.26987542 |
| 168 | DYRK1A | 0.25108981 |
| 169 | PRKCE | 0.24339253 |
| 170 | PRKG1 | 0.22835962 |
| 171 | MELK | 0.21938534 |
| 172 | SMG1 | 0.21153174 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 3.81679122 |
| 2 | Nitrogen metabolism_Homo sapiens_hsa00910 | 3.80576513 |
| 3 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 3.17070212 |
| 4 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 3.01794638 |
| 5 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.83676501 |
| 6 | Arginine biosynthesis_Homo sapiens_hsa00220 | 2.82402323 |
| 7 | Mismatch repair_Homo sapiens_hsa03430 | 2.71421511 |
| 8 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.66185634 |
| 9 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 2.61116448 |
| 10 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 2.56948237 |
| 11 | Propanoate metabolism_Homo sapiens_hsa00640 | 2.50385657 |
| 12 | Tryptophan metabolism_Homo sapiens_hsa00380 | 2.42474675 |
| 13 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 2.37988971 |
| 14 | Proteasome_Homo sapiens_hsa03050 | 2.32167860 |
| 15 | Butanoate metabolism_Homo sapiens_hsa00650 | 2.20143521 |
| 16 | Fatty acid metabolism_Homo sapiens_hsa01212 | 2.19602530 |
| 17 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 2.17046901 |
| 18 | DNA replication_Homo sapiens_hsa03030 | 2.16270952 |
| 19 | Non-homologous end-joining_Homo sapiens_hsa03450 | 2.06409646 |
| 20 | PPAR signaling pathway_Homo sapiens_hsa03320 | 2.05426108 |
| 21 | Peroxisome_Homo sapiens_hsa04146 | 2.01290530 |
| 22 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 2.00301804 |
| 23 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 1.99977447 |
| 24 | * Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 1.94384181 |
| 25 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.94178100 |
| 26 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.82603221 |
| 27 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.73206145 |
| 28 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.71972716 |
| 29 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.67457780 |
| 30 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.65558729 |
| 31 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.64965719 |
| 32 | Histidine metabolism_Homo sapiens_hsa00340 | 1.60241031 |
| 33 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.59335028 |
| 34 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 1.58525802 |
| 35 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.58050550 |
| 36 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.57629984 |
| 37 | * Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.52510895 |
| 38 | Carbon metabolism_Homo sapiens_hsa01200 | 1.51683646 |
| 39 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 1.51103534 |
| 40 | Tyrosine metabolism_Homo sapiens_hsa00350 | 1.49579827 |
| 41 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.48013160 |
| 42 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.44490602 |
| 43 | Bile secretion_Homo sapiens_hsa04976 | 1.44229848 |
| 44 | Retinol metabolism_Homo sapiens_hsa00830 | 1.42693702 |
| 45 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.40767366 |
| 46 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.40278442 |
| 47 | Cell cycle_Homo sapiens_hsa04110 | 1.36663776 |
| 48 | RNA transport_Homo sapiens_hsa03013 | 1.35217272 |
| 49 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.32331194 |
| 50 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.27869116 |
| 51 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.26589943 |
| 52 | Steroid biosynthesis_Homo sapiens_hsa00100 | 1.24692192 |
| 53 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.21625190 |
| 54 | RNA polymerase_Homo sapiens_hsa03020 | 1.16811835 |
| 55 | Spliceosome_Homo sapiens_hsa03040 | 1.14521870 |
| 56 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 1.10211232 |
| 57 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.09886541 |
| 58 | RNA degradation_Homo sapiens_hsa03018 | 1.06617419 |
| 59 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.05851275 |
| 60 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 1.02899602 |
| 61 | Base excision repair_Homo sapiens_hsa03410 | 1.01705790 |
| 62 | Homologous recombination_Homo sapiens_hsa03440 | 1.01536545 |
| 63 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 1.00329877 |
| 64 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.99865776 |
| 65 | ABC transporters_Homo sapiens_hsa02010 | 0.96689629 |
| 66 | Tight junction_Homo sapiens_hsa04530 | 0.86737625 |
| 67 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.85443759 |
| 68 | mRNA surveillance pathway_Homo sapiens_hsa03015 | 0.84660679 |
| 69 | Nucleotide excision repair_Homo sapiens_hsa03420 | 0.84137021 |
| 70 | Adherens junction_Homo sapiens_hsa04520 | 0.82091006 |
| 71 | Basal transcription factors_Homo sapiens_hsa03022 | 0.81957358 |
| 72 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.77254933 |
| 73 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.77213926 |
| 74 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.75159931 |
| 75 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.73861440 |
| 76 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.72629178 |
| 77 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.69676399 |
| 78 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.69639792 |
| 79 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.69421537 |
| 80 | Purine metabolism_Homo sapiens_hsa00230 | 0.68471062 |
| 81 | Sulfur relay system_Homo sapiens_hsa04122 | 0.67823877 |
| 82 | Lysine degradation_Homo sapiens_hsa00310 | 0.67356458 |
| 83 | Protein export_Homo sapiens_hsa03060 | 0.64905801 |
| 84 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.59569819 |
| 85 | Thyroid cancer_Homo sapiens_hsa05216 | 0.54306982 |
| 86 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.53841555 |
| 87 | Insulin resistance_Homo sapiens_hsa04931 | 0.50866525 |
| 88 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.50638876 |
| 89 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 0.50242789 |
| 90 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.50194111 |
| 91 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.49349806 |
| 92 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 0.47279770 |
| 93 | * Metabolic pathways_Homo sapiens_hsa01100 | 0.45211975 |
| 94 | * Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.42167048 |
| 95 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.41615936 |
| 96 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.41569846 |
| 97 | Huntingtons disease_Homo sapiens_hsa05016 | 0.41083725 |
| 98 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.33010848 |
| 99 | Ubiquitin mediated proteolysis_Homo sapiens_hsa04120 | 0.32921934 |
| 100 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.31968570 |
| 101 | TGF-beta signaling pathway_Homo sapiens_hsa04350 | 0.31829363 |
| 102 | Wnt signaling pathway_Homo sapiens_hsa04310 | 0.30329296 |
| 103 | * Galactose metabolism_Homo sapiens_hsa00052 | 0.30207972 |
| 104 | Hippo signaling pathway_Homo sapiens_hsa04390 | 0.29408513 |
| 105 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.27578560 |
| 106 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.27032550 |
| 107 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.25593848 |
| 108 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.23951426 |
| 109 | Prion diseases_Homo sapiens_hsa05020 | 0.19339142 |
| 110 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.17247826 |
| 111 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.16579718 |
| 112 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.15067471 |
| 113 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.11865168 |
| 114 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.10668825 |
| 115 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.06682558 |
| 116 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.05640139 |
| 117 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.02425501 |
| 118 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.01419660 |
| 119 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.01287231 |
| 120 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.00080558 |
| 121 | Circadian rhythm_Homo sapiens_hsa04710 | -0.0901746 |
| 122 | Malaria_Homo sapiens_hsa05144 | -0.0875887 |
| 123 | Mineral absorption_Homo sapiens_hsa04978 | -0.0818742 |
| 124 | Focal adhesion_Homo sapiens_hsa04510 | -0.0809757 |
| 125 | Lysosome_Homo sapiens_hsa04142 | -0.0728875 |
| 126 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | -0.0656364 |
| 127 | Parkinsons disease_Homo sapiens_hsa05012 | -0.0646833 |
| 128 | Amoebiasis_Homo sapiens_hsa05146 | -0.0521172 |
| 129 | Alzheimers disease_Homo sapiens_hsa05010 | -0.0478557 |
| 130 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | -0.0403455 |
| 131 | Protein digestion and absorption_Homo sapiens_hsa04974 | -0.0178020 |
| 132 | Oxidative phosphorylation_Homo sapiens_hsa00190 | -0.0135094 |

